Form D · Biotechnology

ADMA PLASMA BIOLOGICS, INC.

Hackensack, NJ · CIK 0001543433

Offering snapshot reported Feb 28, 2012 · SEC filing

Reported sold
$17.6M
Offering amount: $17.6M
Investors reported
9
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Feb 13, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 28, 2012Initial$17,550,029No comparison9SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$844K
Finders' fees
$0
Form D file number
021-174101
Consideration consisted of cash and promissory notes. Amount above does not include value of placement agent warrant. See Item 15.
In addition to cash fee, placement agent was issued a warrant to purchase 87,865 shares of issuer's common stock at an exercise price of $9.60 per share and was reimbursed for expenses of $100,000.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Rodman & Renshaw, LLC16415

Source: Form D, filed Feb 28, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven A Elms Director
Dov A Goldstein Director
Adam S Grossman Director, Executive
Jerrold B Grossman Director
Eric I Richman Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
65 Commerce Way
Hackensack, NJ, 07601